Dietrich Prof Dr Dr Seidel
#141,020
Most Influential Person Now
Dietrich Prof Dr Dr Seidel's AcademicInfluence.com Rankings
Dietrich Prof Dr Dr Seidelphilosophy Degrees
Philosophy
#7362
World Rank
#10566
Historical Rank
Logic
#4418
World Rank
#5707
Historical Rank
Dietrich Prof Dr Dr Seidelbiology Degrees
Biology
#10001
World Rank
#13278
Historical Rank
Molecular Biology
#1412
World Rank
#1439
Historical Rank
Download Badge
Philosophy Biology
Why Is Dietrich Prof Dr Dr Seidel Influential?
(Suggest an Edit or Addition)Dietrich Prof Dr Dr Seidel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. (1986) (636)
- Low status control, high effort at work and ischemic heart disease: prospective evidence from blue-collar men. (1990) (497)
- Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. (1997) (475)
- A simple specific method for precipitation of low density lipoproteins. (1983) (417)
- Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population (2008) (391)
- A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. (1969) (335)
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) (1994) (332)
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events (2009) (283)
- Simvastatin Initiated Early After Heart Transplantation: 8-Year Prospective Experience (2003) (240)
- Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. (2000) (232)
- Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction (2003) (224)
- Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). (1985) (220)
- Serum CEA and CA 15-3 as prognostic factors in primary breast cancer (2002) (206)
- The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease (1991) (193)
- Nucleosomes in serum of patients with benign and malignant diseases (2001) (185)
- Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring. (1999) (167)
- A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. (1970) (165)
- Nucleosomes in Serum as a Marker for Cell Death (2001) (145)
- Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. (1989) (144)
- Formation of lipoprotein-X. Its relationship to bile compounds. (1976) (143)
- Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. (1988) (140)
- Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. (1997) (134)
- Clinical Relevance of Circulating Nucleosomes in Cancer (2008) (132)
- Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non–Small Cell Lung Cancer (2004) (132)
- Fish oil feeding results in an enhancement of cholesterol-induced atherosclerosis in rabbits. (1987) (130)
- Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. (1987) (125)
- Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin‐induced extracorporeal LDL precipitation (HELP) * (1989) (125)
- Chronic work stress is associated with atherogenic lipids and elevated fibrinogen in middle‐aged men (1997) (122)
- Effect of HELP‐LDL‐apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post‐treatment return to baseline levels (1989) (107)
- Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. (1990) (106)
- PROGNOSTIC VALUE OF INTERLEUKIN 6, PROCALCITONIN, AND C-REACTIVE PROTEIN LEVELS IN INTENSIVE CARE UNIT PATIENTS DURING FIRST INCREASE OF FEVER (2006) (99)
- Improved techniques for assessment of plasma lipoprotein patterns. I. Precipitation in gels after electrophoresis with polyanionic compounds. (1973) (99)
- Alpha-tocopherol down-regulates scavenger receptor activity in macrophages. (1999) (96)
- Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis (1999) (95)
- Circulating Nucleosomes in Serum (2001) (95)
- The role of lipids in nephrosclerosis and glomerulosclerosis. (1994) (95)
- Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. (1991) (89)
- Chemoembolization Combined with Pravastatin Improves Survival in Patients with Hepatocellular Carcinoma (2008) (89)
- Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variation. (1991) (88)
- Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice. (1972) (83)
- Sensitive methods to study human apolipoprotein B metabolism using stable isotope-labeled amino acids. (1996) (79)
- Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer (2008) (78)
- Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. (1990) (75)
- Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations. (1996) (74)
- Imprinted polymers for selective adsorption of cholesterol from gastrointestinal fluids (1998) (74)
- Further Aspects on the Characterization of High and Very Low Density Lipoproteins in Patients with Liver Disease (1972) (72)
- Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat. (1984) (71)
- Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. (1996) (71)
- Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance (2000) (67)
- Atherogenic risk in men suffering from occupational stress. (1988) (67)
- Significance of the LP-X test in differential diagnosis of jaundice. (1973) (67)
- Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors. (1992) (66)
- EXTRACORPOREAL PLASMA TREATMENT FOR THE REMOVAL OF ENDOTOXIN IN PATIENTS WITH SEPSIS: CLINICAL RESULTS OF A PILOT STUDY (2005) (66)
- Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins--reduction of circulating proinflammatory and procoagulatory markers. (2004) (66)
- Apoptosis in serum of patients with solid tumours. (1999) (65)
- Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. (1997) (65)
- Nucleosomes in Serum of Patients with Early Cerebral Stroke (2006) (64)
- Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. (1989) (63)
- Lipoproteins in Liver Disease (1987) (63)
- Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A. (2002) (62)
- Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation. (1997) (60)
- Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. (1993) (59)
- Serum Cholesterol Esterification in Liver Disease. Combined Determinations of Lecithin: Cholesterol Acyltransferase and Lipoprotein‐X (1972) (56)
- Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease. (2000) (56)
- Hypertriglyceridaemia Secondary to Liver Disease (1974) (56)
- Early and Specific Prediction of the Therapeutic Efficacy in Non–Small Cell Lung Cancer Patients by Nucleosomal DNA and Cytokeratin‐19 Fragments (2006) (55)
- Chromatofocusing of human high density lipoproteins and isolation of lipoproteins A and A-I. (1983) (54)
- Quantification of Sirolimus by Liquid Chromatography-Tandem Mass Spectrometry Using On-Line Solid-Phase Extraction (2002) (53)
- Hypertriglyceridaemia Secondary to Liver Disease (1974) (53)
- The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans. (2001) (50)
- Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia. (2006) (49)
- Evaluation and routine application of the novel restricted-access precolumn packing material Alkyl-Diol Silica: coupled-column high-performance liquid chromatographic analysis of the photoreactive drug 8-methoxypsoralen in plasma. (1995) (49)
- Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis. (1999) (49)
- Serum cholesterol and mortality in patients with multiple organ failure. (2000) (49)
- The prognostic value of hypocholesterolemia in hospitalized patients (1994) (49)
- Selective removal of low density lipoproteins (LDL) by precipitation at low pH: First clinical application of the HELP system (1987) (48)
- Nucleosomes as a new prognostic marker in early cerebral stroke (2007) (47)
- Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation. (1991) (45)
- Improved assessment of plasma lipoprotein patterns. III. Direct measurement of lipoproteins after gel-electrophoresis. (1977) (44)
- Safety and effectiveness of long-term LDL-apheresis in patients at high risk. (1998) (43)
- Coupled-column liquid chromatographic analysis of epirubicin and metabolites in biological material and its application to optimization of liver cancer therapy. (1995) (43)
- On the metabolism of lipoprotein-X (LP-X). (1976) (41)
- Nucleosomes in Pancreatic Cancer Patients during Radiochemotherapy (2005) (41)
- Improved techniques for assessment of serum lipoprotein patterns. II. Rapid method for diagnosis of type 3 hyperlipoproteinemia without ultracentrifugation. (1973) (40)
- Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study. (1999) (40)
- Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. (1996) (39)
- HMG-CoA reductase inhibitors (1998) (39)
- Identification of the protein moiety of an abnormal human plasma low‐density lipoprotein in obstructive jaundice (1969) (39)
- Psychosocial and biobehavioral characteristics of hypertensive men with elevated atherogenic lipids. (1991) (38)
- Improved assessment of plasma lipoprotein patterns. IV. Simple preparation of a lyophilized control serum containing intact human plasma lipoproteins. (1982) (38)
- Characterization of five mouse monoclonal antibodies to apolipoprotein[a] from human Lp[a]: evidence for weak plasminogen reactivity. (1989) (37)
- Selective continuous extracorporal elimination of low-density lipoproteins with heparin at acidic pH. (1983) (36)
- Higher blood–brain barrier penetration of [14C]apalutamide and [14C]enzalutamide compared to [14C]darolutamide in rats using whole-body autoradiography. (2019) (35)
- Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease. (1999) (34)
- A new immunochemical technique for a rapid, semi-quantitative determination of the abnormal lipoprotein (LP-X) characterizing cholestasis. (1971) (34)
- Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different pathophysiological approach. (2001) (33)
- Isolation and analysis of human plasma lipoproteins accumulating postrandial in an intermediate density fraction (d 1.006--1.019 g-ml). (1974) (33)
- H.E.L.P. apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience. (1996) (32)
- Diagnosis of extrahepatic biliary obstruction in infants by immunochemical detection of LP-X and modified 131 I-Rose Bengal excretion test. (1973) (32)
- HELP apheresis in the treatment of sepsis. (1998) (32)
- Nucleosomes in Colorectal Cancer Patients during Radiochemotherapy (2006) (32)
- Human lysosomal acid lipase/cholesteryl ester hydrolase and human gastric lipase: identification of the catalytically active serine, aspartic acid, and histidine residues. (1997) (32)
- No evidence for feedback inhibition of hepatic apolipoprotein B (apo B) production after extracorporeal low density lipoprotein precipitation as determined by [I‐13C]leucine infusion in normal volunteers (1993) (32)
- Determination of apolipoprotein A-I by kinetic nephelometry. (1981) (31)
- The acid lipase gene family: three enzymes, one highly conserved gene structure. (1997) (30)
- Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments (2006) (28)
- Determination of apolipoprotein B by kinetic (rate) nephelometry. (1982) (27)
- Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction. (2004) (27)
- Blood-brain barrier penetration of [14C]darolutamide compared with [14C]enzalutamide in rats using whole body autoradiography. (2018) (26)
- Direct method for measuring lipoprotein-X in serum. (1975) (26)
- Does lipoprotein-X (LP-X) act as a substrate for the lecithin: cholesterol acyltransferase (LCAT)? (1973) (26)
- Efficacy of Lipid Apheresis: Definitions and Influencing Factors (1995) (25)
- Validation of an Automated Enzyme Immunoassay for Interleukin-6 for Routine Clinical Use (1998) (25)
- Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels. (1994) (25)
- Complement activation and depletion during LDL‐apheresis by heparin‐induced extracorporeal LDL‐precipitation (HELP) (1991) (23)
- Serum lipoproteins and coronary artery disease (CAD) Comparison of the lipoprotein profile with the results of coronary angiography (1980) (23)
- Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure. (1993) (23)
- Human lysosomal acid lipase/cholesteryl ester hydrolase and human gastric lipase: site-directed mutagenesis of Cys227 and Cys236 results in substrate-dependent reduction of enzymatic activity. (1997) (22)
- Ultracentrifugal characterization of a lipoprotein occurring in obstructive jaundice. (1969) (22)
- CD36 mRNA EXPRESSION IS INCREASED IN CD14+ MONOCYTES OF PATIENTS WITH CORONARY HEART DISEASE (2008) (22)
- [An abnormal low density lipoprotein in cholestaris. II. Significance for the differential diagnosis of jaundice]. (1970) (21)
- Plasma lipoproteins in patients with familial plasma lecithin: cholesterol acyltransferase (LCAT) deficiency--studies on the apolipoprotein composition of isolated fractions with identification of LP-X. (1974) (21)
- The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels. (1999) (21)
- Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Göttingen Risk, Incidence, and Prevalence Study (GRIPS). (1988) (21)
- Selective Continuous Extracorporeal Elimination of Low-Density Lipoproteins from Plasma by Heparin Precipitation without Cations (1983) (21)
- II. ISOLATION AND PARTIAL CHARACTERIZATION OF THE PROTEIN MOIETIES OF LOW DENSITY LIPOPROTEINS (1970) (20)
- The HELP system: an efficient and safe method of plasma therapy in the treatment of severe hypercholesterolemia. (1990) (20)
- Coupled-column HPLC analysis of free urinary catecholamines using restricted access affinity precolumn and micro-particulate nonporous silica analytical column (1995) (19)
- Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor (1988) (19)
- Procalcitonin, a new indicator for non-viral infections in heart, lung or liver transplant patients. (1999) (19)
- Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography. (2005) (18)
- The beneficial influence of nifedipine on the regression of the cholesterol-induced atherosclerosis in rabbits (1987) (18)
- Serum Cholesterol Levels in Neutropenic Patients with Fever (2002) (18)
- [Lipoprotein electrophoresis in the diagnosis of hyperlipoproteinemia]. (1970) (18)
- Reversible reduction of phospholipid bound arachidonic acid after low density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membrane. (1994) (17)
- Expression of vascular cell adhesion molecule-1 (VCAM-1) in the aortae of hypercholesterolemic rabbits with high (HAR) and low (LAR) atherosclerotic response. (1997) (17)
- Hyperlipoprotein(a)aemia in nephrotic syndrome (1996) (17)
- Heparin-mediated extracorporeal LDL/fibrinogen precipitation--H.E.L.P.--in coronary and cerebral ischemia. (1999) (17)
- Selective continuous elimination of low density lipoproteins (LDL) by heparin precipitation: first clinical application. (1986) (16)
- Isolation and characterization of lipoprotein‐X (LP‐X) from canine (1973) (16)
- The Efficacy and Safety of the New Heparin‐induced Extracorporeal Low‐density Lipoprotein Precipitation System (Plasmat Futura) in Comparison with the Currently used System (Plasmat Secura) (2004) (16)
- Die Lipoproteinelektrophorese zur Diagnose von Hyperlipoproteinämien (1970) (16)
- Low atherosclerotic response of a strain of rabbits to diet-induced hypercholesterolemia. (1995) (16)
- Recent developments in low-density lipoprotein apheresis (1992) (16)
- Serum lipoproteins and coronary artery disease (CAD). Comparison of the lipoprotein profile with the results of coronary angiography. (1980) (15)
- Quantification of plasma lipoprotein cholesterol: a simple procedure for enzymatic determination of cholesterol in electrophoretically separated lipoproteins. (1980) (15)
- Cross-linked iron dextran is an efficient oral phosphate binder in the rat (1996) (15)
- Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia. (2002) (15)
- Removal of low‐density lipoproteins (LDL) and fibrinogen by precipitation with heparin at low pH: Clinical application and experience (1988) (15)
- IN VIVO STUDIES ON THE METABOLISM OF [15,16‐3H]TETRACOSANOIC ACID (LIGNOCERIC ACID) IN ADULT RAT BRAIN (1975) (15)
- LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia. (1993) (14)
- Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease. (2004) (14)
- [A new and simplified method for the detection of LP-X, a cholestasis specific lipoprotein]. (1973) (14)
- Long-term experience with the HELP system for treatment of severe familial hypercholesterolemia. (1987) (14)
- An optimized method for measuring lecithin : cholesterol acyltransferase activity, independent of the concentration and quality of the physiological substrate. (1981) (14)
- Late-onset metachromatic leukodystrophy: Diagnostic problems elucidated by a case report (2004) (13)
- Sensitive Mass Spectrometry Techniques for Measuring Metabolism of Human Apolipoprotein B In Vivo (1994) (13)
- Apolipoprotein AIMarburg: Studies on two kindreds with a mutant of human apolipoprotein AI (2004) (12)
- Risk factor patterns for coronary heart disease in China, Japan and Germany. (1992) (12)
- Coronary Risk Factors in China: A Comparative Study of Middle-aged Workers in China and Germany (1987) (12)
- Characterization and Extracorporeal Application of a New Phosphate-Binding Agent (1994) (12)
- Effects of medrogestone and conjugated oestrogens on serum lipid and lipoprotein concentrations. (1985) (12)
- Pravastatin--ocular side effects after a two year follow-up? (1990) (12)
- Evaluation of the First Automated Thyroglobulin Assay (1999) (11)
- Technique of immunoapheresis in heterotopic and orthotopic xenotransplantation of pig hearts into cynomolgus and rhesus monkeys. (2000) (11)
- Role of lipoproteins in progressive renal disease. (1993) (11)
- Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP). (1992) (11)
- Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP). (1988) (11)
- Cytokine and cytokine-receptor profiles after liver and heart transplantation. (1995) (10)
- 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up. (1992) (10)
- Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats (1981) (10)
- Diabetic microangiopathy and blood viscosity changes after pancreas and kidney transplantation. (1994) (10)
- Influence of smoking on the plasma lipoprotein profile. (1984) (9)
- [Oestrogen as a risk factor for the vascular system (author's transl)]. (2008) (9)
- Cross-linked iron dextran is an efficient oral phosphate binder in the rat. (1996) (9)
- Human Plasma Lipoproteins: Biochemical and Clinical Aspects (1982) (9)
- Lipid metabolic changes during hormonal treatment of endometriosis. (1988) (9)
- Case reports on emergency treatment of cardiovascular syndromes through heparin-mediated low-density lipoprotein/fibrinogen precipitation: a new approach to augment cerebral and myocardial salvage. (2002) (9)
- [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)]. (2003) (9)
- Identification of the protein moiety of the LP(a)‐lipoprotein in human plasma (1971) (8)
- Medroxyprogesterone acetate and lipid metabolic changes. (1987) (8)
- Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemia. (1989) (8)
- Simvastatin added to ursodeoxycholic acid does not enhance disappearance of gallstone fragments after shock wave therapy. (1995) (8)
- Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation. (1990) (8)
- Reverse Flux Filtration: A New Mode of Therapy Improving the Efficacy of Heparin - Induced Extracorporeal Ldl Precipitation in Hyperlipidemic Hemodialysis Patients (1993) (8)
- The H.E.L.P. system: an efficient and safe method for plasma therapy in the treatment of severe hypercholesterolemia. (1996) (8)
- Use of procalcitonin as indicator of nonviral infections in transplantation and related immunologic diseases (2000) (7)
- Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patients. (1999) (7)
- Considerations about plasma fibrinogen concentration and the cardiovascular risk: combined evidence from the GRIPS and ECAT studies. Goettingen Risk Incidence and Prevalence Study. European Concerted Action on Thrombosis and Disabilities. (1996) (7)
- Prevention and treatment of graft vessel disease after heart transplantation. (1995) (7)
- A novel mutation in the neonatal region of the fibrillin (FBN) 1 gene associated with a classical phenotype of Marfan syndrome (MfS) (1998) (7)
- Low-density lipoprotein plasmaphaeresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolaemia (1990) (7)
- Mass Spectrometry in Medicine - the Role of Molecular Analyses (2007) (6)
- [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up]. (1995) (6)
- Acute and long-term effects of low-density lipoprotein apheresis on the serum concentrations of vitamins E and A (1988) (6)
- Simultaneous heparin extracorporeal LDL precipitation and hemodialysis. First clinical experience. (1991) (6)
- Ocular side effects of the lipid-lowering drug simvastatin? A one year follow-up. (1989) (6)
- TACROLIMUS AND MMF IN CARDIAC TRANSPLANTATION: IMPORTANCE OF MYCOPHENOLIC ACID DRUG MONITORING (1998) (6)
- The HELP System: A Novel Technique for the Extracorporeal Treatment of Familial Hypercholesterolemia (1987) (6)
- Lipoprotein Lp(a): Structure and Metabolism (1989) (6)
- Heparin-induced extracorporeal low-density-lipoprotein plasmapheresis (HELP) and its use in heart transplant patients with severe hypercholesterolemia. (1995) (6)
- HER-2/neu in tissue and serum at time of primary diagnosis of breast cancer. (2009) (6)
- Efficacy of low-density-lipoprotein lowering with statins (1994) (6)
- Relation between renal and hepatic excretion of drugs: X. Excretion of nalorphine in young and adult rats pretreated with hormones or xenobiotics. (1988) (5)
- Influence of bile acids and free fatty acids on physicochemical properties of LP-X (1978) (5)
- CA 125 in the early detection of metastatic breast cancer. (2009) (5)
- Electron microscopy of low-density plasmalipo-proteins in patients with type IIa hyperlipoproteinemia (1973) (5)
- Synthesis of carbon‐14 labelled moxifloxacin hydrochloride (2000) (5)
- [Hyperlipoproteinemia and LDL apheresis. Clinical experiences with the H.E.L.P. system]. (2001) (5)
- Labelling of the guanylate cyclase activator cinaciguat (BAY 58‐2667) with carbon‐14, tritium and stable isotopes (2010) (5)
- [Hyperlipoproteinemia in liver diseases]. (1975) (5)
- A novel mutation in the neonatal region of the fibrillin (FBN)1 gene associated with a classical phenotype of Marfan syndrome (MfS). Mutations in brief no. 163. Online. (1998) (5)
- Hyperlipoproteinemias and liver disease. (1973) (5)
- [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]. (2003) (5)
- What is the role of lipid lowering therapy in heart-allograft failure? (1995) (4)
- [Automated platelet count in thrombocytopenic patients--a comparison of methods]. (1985) (4)
- Lipoprotein electrophoresis in the diagnosis of the hyperlipoproteinaemias. (1971) (4)
- Heparin-mediated extracorporeal LDL precipitation treating a peripheral arterial disease patient suffering from repeated postoperative bypass occlusion. (2005) (4)
- Pharmacokinetics of repinotan in healthy and brain injured animals (2005) (4)
- Properties of the abnormal human plasma lipoprotein (LP-X) characteristic of cholestasis after chemical modification with succinic anhydride. (1974) (4)
- Treatment of hypercholesterolemia and prevention of coronary artery disease after heart transplantation by combination of low-dose simvastatin and HELP-LDL-apheresis. (1992) (4)
- Syntheses of [14C]BAY 59-7939 and its radiolabeled metabolite M-4 (2006) (4)
- Influence of smoking on cellular lipid metabolism. (1984) (4)
- Extracorporeal plasma therapy: the HELP system for the treatment of hyper-beta-lipoproteinemia. (1988) (4)
- An investigation of the lipoprotein profiles of patients on hemofiltration as compared to those on hemodialysis and intermittent peritoneal dialysis. (1982) (4)
- Luminescence in the study of lipid metabolism. (1989) (4)
- Incidence and mortality rates of myocardial infarction in Chinese workers aged 40–59 in relation to coronary risk factors (1991) (4)
- Differences in the risk factor patterns for coronary heart disease in China, Japan, and Germany (1991) (4)
- [Accuracy of HDL cholesterol measurements]. (1983) (4)
- [Cytokine analysis. What is feasible--what is useful?]. (2001) (4)
- [Extracorporeal plasma therapy in disorders of lipid metabolism: report of experiences with the H.E.L.P. system]. (1992) (3)
- 9thConference of the Central European Division e.V. of the International Isotope Society: Some selected abstracts relevant for radiosynthesis and applications of labelled compounds (2001) (3)
- A simple turbidimetric assay designed for the routine screening as well as therapeutic monitoring of native LDL particles. (2001) (3)
- [Advances in the analysis of plasma lipoproteins. A new possibility for differential diagnosis of icterus]. (1970) (3)
- [Determination of LDL and beta-cholesterol in serum. Clinical significance and methodologic possibilities]. (1987) (3)
- Plasma lipoproteins in patients with familial plasma lecithin: cholesterol acyltransferase deficiency: apolipoprotein composition of isolated fractions. (1972) (3)
- Long‐term follow‐up of lipid metabolism and rheologic properties after successful pancreas and kidney transplantation (1994) (3)
- Synthesis of [14C]-labelled repinotan hydrochloride and its major metabolite M-6 (2002) (3)
- Determinants of natriuretic peptides in early septic shock (1998) (3)
- Isolation of apolipoprotein-B-48 from chylomicrons by high-performance liquid chromatography. (1987) (3)
- Hypocholesterolemia in cancer (2000) (3)
- Is a reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible? (1995) (3)
- Pharmacokinetics and Excretion of 14C-Labeled Polyethylene Glycol (60 kDa) in Rats (2014) (2)
- [Lovastatin efficacy and tolerance in primary hypercholesterolemia. The German Lovastatin Study Group]. (1991) (2)
- 4.P.231 Metabolism of triglyceride-rich lipoproteins determines occurrence of atherogenic LDL phenotype (1997) (2)
- Risk Factors for Atherosclerosis in the Federal Republic of Germany, Japan, and the People’s Republic of China (1988) (2)
- Amelioration of lipid induced glomerulopathy by lovastatin (2000) (2)
- MPA-dose adjustment based on trough levels- high and low dose pharmacokinetics in heart transplanted patients (1999) (2)
- Carbon-14 labelling of acarbose – a challenge over more than 20 years† (2007) (2)
- Postoperative Heparin-Mediated Extracorporeal Low-Density Lipoprotein Fibrinogen Precipitation Aphaeresis Prevents Early Graft Occlusion after Coronary Artery Bypass Grafting (2016) (2)
- [Maximal therapy of hypercholesterolemia in coronary heart disease]. (1990) (2)
- [Comparative hemolysis studies of various dialysis technics]. (1985) (2)
- The complex isotopologue space of glucose as a framework for the study of human intermediary metabolism (2015) (2)
- 4.P.255 Lipid and apolipoprotein composition of lipoproteins in hypocholesterolemia of sepsis (1997) (2)
- [Studies on the structure and metabolism of lipoprotein-X (LP-X), the abnormal plasmalipoprotein in cholestasis (author's transl)]. (1977) (2)
- Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia (1990) (2)
- Ranking of Lp(a) as a risk factor: results from a 10-year prospective study (1994) (2)
- Analysis of Polymers with Light Scattering Detection A comparative Overview of Measuring Principles (2004) (2)
- [The significance of LP-X cholesterol in the differential diagnosis of cholestasis (author's transl)]. (1982) (2)
- The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19 (2022) (2)
- Transcatheter chemoembolization of hepatocellular carcinoma : a study of the pharmacokinetics of epirubicin with LipiodolR or starch microspheres as embolizing agent (1996) (2)
- Rate-Nephelometry of A-I and Electrophoresis (1980) (2)
- [Lipoproteins in liver diseases]. (1975) (2)
- MMF-DOSE ADJUSTMENTS BASED ON MPA-TROUGH LEVELS AFTER HEART TRANSPLANTATION: DIFFERENCE BETWEEN HIGH AND LOW DOSE PHARMACOKINETICS (1999) (2)
- Structure of lipoprotein-X. (1972) (1)
- [Coronary heart disease in childhood in familial hypercholesteremia. Maximum therapy with LDL apheresis]. (2003) (1)
- ELIMINATION OF LPS AND / OR TNF&agr; FROM HUMAN PLASMA BY ADSORPTION‐APHERESIS: 643 (1997) (1)
- The H.E.L.P. System : Clinical Experience of 10 Years - A Report(Workshop1-12) (1996) (1)
- The cardiopulmonary bypass supported high-risk PTCA (CPB-PTCA): a useful model for the study of CPB-dependent systemic inflammatory response syndrome (SIRS)? (1997) (1)
- 148 HIGH SOLUBLE TNF RECEPTOR P55 LEVELS EARLY PREDICT OUTCOME IN SCORE-IDENTIFIED POST-CARDIAC SURGICAL PATIENTS AT HIGH RISK FOR SEPSIS (1995) (1)
- [Significance of age, relative body weight, smoking habits and alcohol drinking for the incidence of atherogenic lipid metabolism patterns]. (1986) (1)
- [The problems of lipid metabolism. Demands for diagnostically improved insight into the function of lipoproteins (author's transl)]. (1979) (1)
- [Risk of myocardial infarct in 40 to 60-year-old males in relation to potential risk factors of atherosclerosis. Intermediate evaluation of the Göttingen risk, incidence and prevalence study following a 5-year observation period]. (1989) (1)
- [Prevention of cardiovascular diseases by intervention in lipid metabolism]. (1992) (1)
- [Candidate selected method for the enzymatic determination of total cholesterol in serum]. (1983) (1)
- [Lipoproteins in renal hypertension]. (1982) (1)
- Advances in Lipoprotein Research (1973) (1)
- [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy]. (2003) (1)
- [Diurnal patterns of plasma lipids and lipoproteins in primary endogenous hypertriglyceridemia (type IV-hyperlipoproteinemia) (author's transl)]. (1977) (1)
- [Various HMG-CoA reductase inhibitors]. (1999) (1)
- Biochemistry of Plasmalipoproteins in Liver Diseases (1978) (1)
- Extracorporal Plasma Therapy in the Treatment of Severe Hyper-β-Lipoproteinemia (1988) (1)
- Early prediction of response to chemotherapy by circulating nucleosomes and CYFRA 21-1. (2004) (1)
- A lipoprotein characterizing obstructive jaundice: isolation and analysis. (1970) (1)
- Workshop: Plasma Lipoproteins (1974) (1)
- [The influence of oral contraceptives on lipoprotein status (author's transl)]. (2008) (1)
- Maximal treatment of hypercholesterolemia in coronary heart disease (CHD): clinical utility of heparin-induced plasmapheresis (HELP) (1994) (1)
- [New strategies in treatment of severe hypercholesterolemia in coronary patients: HMG-CoA reductase inhibitors and H.E.L.P.-LDL apheresis]. (1992) (1)
- APOLIPOPROTEIN-E AND APOLIPOPROTEIN-B CONCENTRATIONS IN CEREBROSPINAL-FLUID (1990) (1)
- [Prevention of coronary atherosclerosis. Determination and evaluation of lipid metabolism values]. (1995) (1)
- CHROMATOFOCUSING OF HIGH DENSITY LIPOPROTEINS (1983) (1)
- 813-3 Reduction of plasma cholesterol and fibrinogen by H.E.L.P. apheresis increases myocardial perfusion in heart transplant patients (2004) (1)
- Quantitative fluorimetric assay of LDL- and scavenger-receptor activity in cultured cells (1995) (1)
- How Important is Lp(a) for a Clinical Decision (1993) (1)
- (R) - (-) - 2- {N- [4- (1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl) butyl] aminomethyl} chroman crystalline hydrochloride, for the preparation and pharmaceutical compositions containing the compounds of the process (1996) (0)
- Use of heparin derivatives for the selective extracorporeal precipitation of low density lipoproteins from full serum or plasma (1984) (0)
- [Proceedings: Normal values and samples of findings in primary and secondary hyperlipoproteinemia]. (1975) (0)
- The Munich Coronary Bypass Intervention Study (MCBIT): goals, design, first results (1994) (0)
- Method and apparatus for the simultaneous extracorporeal elimination of tumor necrosis factor alpha and bacterial lipopolysaccharides from whole blood or / and blood plasma (1995) (0)
- Use of tentacle cation-exchangers, fibrinogen for the selective elimination of low-density lipoproteins (LDL) and / or urea from liquids (1989) (0)
- Re: Fish oil feeding results in enhancement of cholesterol-induced atherosclerosis in rabbits: A reply to the Letter of T.A.B. Sanders (1987) (0)
- Impact of simvastatin after heart transplantation – A ten year experience (2004) (0)
- 176 In vitro human metabolism of BAY 57-9352: a novel VEGFR-2/PDGFR kinase inhibitor (2004) (0)
- Differences and regulation of scavenger receptor activity in rabbit fibroblasts and smooth muscle cells (1994) (0)
- TGF-β binding in various cell lines and its effect on LDL uptake (1995) (0)
- [Lipoproteins as risk indicators of coronary heart disease in females. Partial report of the Goettingen Risk, Incidence and Prevalence Study (GRIPS)]. (1986) (0)
- TREATMENT OF PRIMARY LIVER GRAFT DYSFUNCTION AND SEPTIC LIVER FAILURE WITH ALBUMIN DIALYSIS: 525 (2004) (0)
- [Can hyperlipidemia after heart transplantation be optimally and safely treated?]. (1994) (0)
- ImprovedAssessmentof PlasmaLipoproteinPatterns : IV . Simple Preparationof a LyophilizedControlSerum ContainingIntactHuman PlasmaLipoproteins (2004) (0)
- [A simple method for the determination of enzyme activities in turbid plasma of patients with hyperlipoproteinemia (author's transl)]. (1974) (0)
- [An abnormal low-density lipoprotein in cholestases. I. Isolation and characterization]. (1970) (0)
- Scavenger receptor activity in macrophages from rabbits with high (HAR) and low (LAR) atherosclerotic response (1999) (0)
- [Can the determination of drug levels improve therapy?]. (1984) (0)
- Utility of tumor markers for the early detection of metastatic breast cancer (2008) (0)
- H.E.L.P.-APHERESIS FOR PREVENTION OF GRAFT VESSEL DISEASE AFTER HEART TRANSPLANTATION (1996) (0)
- Fluorescence based detection of the CETP TaqIB polymorphism: Identification of a new C775T polymorphism in intron 1 by melting curve analysis (2000) (0)
- Effect of LP-X on Hepatic Cholesterol Synthesis (1983) (0)
- A simple method for the determination of enzyme activities in turbid plasma of patients with hyperlipoproteinemia. (1974) (0)
- [Description of a special form of postprandial hyperlipidemia: possible cause of premature coronary heart disease]. (1990) (0)
- Handbook of internal medicine. Volume 7. Metabolic disorders. 4. Fat metabolism. (1976) (0)
- The HELP-system in the treatment of severe hypercholesterolaemia: acute and long-term experience. (1991) (0)
- [Plasma lipids. Tasks and possibilities of the special laboratory. Future developments]. (1980) (0)
- Pilot study of postoperative HELP-apheresis to prevent early graft occlusion after coronary artery bypass grafting (2007) (0)
- Sepsis-induced hypocholesterolemia (2000) (0)
- [Early detection and incidence of iron deficiency in pregnancy]. (1986) (0)
- Low molecular weight heparin vs. standard heparin in haemodialysis/haemofiltration patients: Results of a multicentre long-term study (1987) (0)
- Biochemical and clinical aspects of various lipoprotein patterns. (1973) (0)
- 1.P.112 Increased scavenger receptor activity in macrophages from rabbits with low atherosclerotic response (LAR-rabbits) (1997) (0)
- [Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors]. (1985) (0)
- [Lipoprotein changes during hormonal treatment of endometriosis with lynestrenol and danazol]. (1984) (0)
- [Need for treatment and treatment possibilities of hypercholesterolemia]. (1990) (0)
- Obtaining biological components from body fluids. (2000) (0)
- Clinical utility of the H.E.L.P.-treatment in heart transplant patients (1995) (0)
- H.E.L.P. IN SEPTICEMIA : FIRST CLINICAL EXPERIENCES (1996) (0)
- 2.P.359 Is plasma fibrinogen before heart transplantation an independent predictor of graft vessel disease (1997) (0)
- Severe hyperlipoprotein(a)emia in nephrotic syndrome (1994) (0)
- Clinical utility of the H.E.L.P. treatment—ten years of experience (1995) (0)
- 2.P.126 Studies of the 5′-region of the apolipoprotein(a) gene in HepG2 cells by luciferase reporter gene assays (1997) (0)
- 3.P.361 Interleukin-6 correlates with hypocholesterolemia in inflammatory disease and stimulates LDL receptor activity in HepG-2 cells (1997) (0)
- The cardiopulmonary bypass supported high‐risk PTCA (CPB‐PTCA) as a model for the study of CPB‐SIRS‐induced myocardial depresssion: 354 (1997) (0)
- Use of phosphatadsorbent for the treatment of vascular disease (2002) (0)
- Beneficial effects of acute HELP apheresis treatment in disorders of microcirculation (1994) (0)
- Adsorbent for the prevention or treatment of severe cases of infectious diseases (2016) (0)
- Device for the elimination of lipopolysaccharide and / or bacterial from protein-containing liquids lipoteichoic acids, and their use for the treatment of sepsis. (2004) (0)
- Improved survival after diagnosis of cardiac allograft vasculopathy (CAV) through extreme reduction of cholesterol and fibrinogen (2003) (0)
- Use of an agent and device for simultaneous extracorporeal elimination of tumor necrosis factor alpha and bacterial lipopolysaccharides from whole blood or / and blood plasma (1995) (0)
- Rauchen als Faktor (1986) (0)
- [Lipoprotein (a)]. (1991) (0)
- [Characteristic lipoprotein changes in hyperthyroidism]. (1975) (0)
- [Serum magnesium concentration in myocardial infarct]. (1986) (0)
- Modulation of LDL uptake in various cultured cell lines by cytokines and growth factors (1995) (0)
- P-422 Prognostic factors in patients with advanced lung cancer (2003) (0)
- [Plasma lipoproteins: characterisation and clinical importance]. (1971) (0)
- [Hyperlipoproteinemia in liver diseases]. (1978) (0)
- [Hyperlipoproteinemia Type 3. The possibility of an immunological diagnosis]. (1970) (0)
- Advances in lipoprotein research. Biochemical and clinical aspects. (1973) (0)
- [Effect of lipoprotein X on the cholesterol synthesis in the rat liver]. (1976) (0)
- Direct Methodfor MeasuringLipoprotein-Xin Serum (1975) (0)
- Peculiar quantifying method for ldl in serum sample and reagent for it (1993) (0)
- Utilization of an adsorbent material type phosphates against vascular diseases. (2002) (0)
- Method and apparatus for the selective separation of pathological and / or toxic species from blood or blood plasma using filter candles (1984) (0)
- 24. The Presence of an Abnormal Low‐Density Lipoprotein in the Serum of Infants with Chronic Obstructive Jaundice (1969) (0)
- Effects of HMG-CoA reductase inhibitors on endotoxin induced release of TNF and IL-6 in whole blood system (2000) (0)
- [Quantitative lipid electrophoresis]. (1971) (0)
- Use of a modified with polynuclear metal adsorbent material for the selective elimination of inorganic phosphate from protein-containing liquids (1992) (0)
- Significance and Need of Screening for Hyperlipidemia in Childhood (1980) (0)
- Isolation and characterization of lipoprotein-X from the pig. (1977) (0)
- A New, Sensitive Method for Measuring Low-Density Lipoproteins and Its Application to the Screening for Hyperlipoproteinemia (1984) (0)
- Advances in lipoprotein research: biochemical and clinical aspects. (1973) (0)
- Influence of age, body-weight, smoking habits and alcohol consumption on the lipoprotein profile: preliminary results from a study performed on 6543 male industrial workers aged 40-59 years. (1984) (0)
- Process for quantitative selective removal or preparative isolation of tumour necrosis factor or/and lipopolysaccharides from aqueous liquid, device for extracorporeal removal of tumour necrosis factor and/ or lipopolysaccharides from liquid and its device unit and adsorption material (1993) (0)
- On-line SPE-LC-ECD analysis of catecholamines in urine and plasma (2004) (0)
- Dietary Management of Atherosclerosis (1977) (0)
- Characteristic plasma lipoprotein pattern in patients suffering from hyperthyroidism. (1973) (0)
- 4.P.248 PFGF-AA is responsible for the stimulatory effect of conditioned medium from colon carcinoma cell line (SW480) on LDL receptor activity or proliferation in cultured skin fibroblasts (1997) (0)
- Occupational risks in blue collar men suffering from hyperlipidemia and hypertension (1988) (0)
- 027 Simplified chromatographic isolation of sex hormone-binding globulin from follicular fluid (1992) (0)
- Formation and Structural Properties of Lipoprotein-X (1977) (0)
- A method for quantitative selective removal or preparative recovery of tumor necrosis factor (TNF) and / or lipopolysaccharides (LPS) from aqueous liquids (1993) (0)
- Fibrinogen/LDL-apheresis in the treatment of sudden hearing loss: A prospective, randomized multicenter trial (2003) (0)
- Extracorporal Plasma Therapy in the Treatment of Severe Hyper-β-lipoproteinemia: The HELP System (1988) (0)
- Role of vascular endothelial cells plated on culture dishes and polyurethane patch in inflammation: an in vitro study (1994) (0)
- [Atherogenesis: interplay between cholesterol, inflammation and coagulation]. (2005) (0)
- [Disorders of lipid metabolism: pathophysiology, diagnosis, pathogenesis and therapy]. (1987) (0)
- P-421 Early prediction of the response to chemotherapy in patients with lung cancer by the course of apoptotic markers in serum (2003) (0)
- [Plasma lipoproteins in humans: metabolism and relation to atherosclerosis]. (1984) (0)
- PROBLEM RANGE EVALUATION OF THE HEMATOLOGY ANALYZERS ABBOTT CELL DYN 3500,COULTER STKS, SYSMEX SE-9000 AND TECHNICON H*3 : ANALYSIS OF LEUKOPENIC AND THROMBOPENIC SAMPLES, WBC DIFFERENTIALS AND FLAGGING PERFORMANCE (1998) (0)
- Apparatus for the removal of bacterial lipopolysaccharides and / or lipoteichoic acids from protein-containing liquids as well as use for the preparation of an agent for the removal of these substances (2004) (0)
- Advances in lipoprotein research. Biochemical and clinical aspects. (1973) (0)
- Influence of known risk factors on the lipoprotein profile. (1986) (0)
- [Advances in lipoprotein research: biochemical and clinical aspects (author's transl)]. (1974) (0)
- A process for the simultaneous removal of tumor necrosis factor alpha and bacterial lipopolysaccharides from an aqueous liquid (1994) (0)
- Method and device for the specific adsorption of heparin (1984) (0)
- [Normal values and pattern of findings in primary and secondary hyperlipoproteinemias]. (1975) (0)
- APPLICATION OF A SELECTIVE ADSORPTION SYSTEM FOR ENDOTOXIN: 252 (2004) (0)
- crystalline hydrochloride (r) - (-) - 2- (N- (4- (1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl) -butyl) aminomethyl) -chromane . (1996) (0)
- [Proceedings: Normal ranges and pattern of findings in primary and secondary hyperlipoproteinemia]. (1975) (0)
- [Lipoprotein metabolism (author's transl)]. (1980) (0)
- Process for the selective elimination of inorganic phosphate from liquids by means of modified with polynuclear metal adsorption (1992) (0)
- [Dyslipoproteinemia in disorders of liver function]. (1981) (0)
- ImprovedTechniquesforAssessmentof PlasmaLipoprotein Patterns. I. Precipitation inGelsafterElectrophoresis with Polyanionic Compounds (1973) (0)
- 15th Workshop of the International Isotope Society–Central European Division: The synthesis and applications of isotopes and isotopically labelled compounds Bad Soden, Germany, June 12–13, 2008 (2009) (0)
- Electron microscopy immunology and clinical significance of the abnormal density lipoprotein in obstructive jaundice (LP-X) 197 (1972) (0)
- [Cleaning of turbid sera before enzyme determinations]. (1974) (0)
- Interleukin 6, procalcitonin and CRP levels during first increase of fever in intensive care patients 1 (2008) (0)
- 3.P.46 Effect of α-tocopherol on scavenger receptor activity, mRNA — expression and regulation in macrophages (1997) (0)
- [Diurnal changes in lipoproteins in patients with hyperlipoproteinemia type IV]. (1975) (0)
- Clinical Utility of TNF‐R I,II assays: 693 (1997) (0)
- Coupled-column HPLC analysis of free urinary catecholamines using restricted access affinity precolumn and micro-particulate nonporous silica analytical column (1995) (0)
- PD-072 Circulating nucleosomes and cyfra 21-1 predict early theresponse to chemotherapy in patients with advanced non-small cell lung cancer (2005) (0)
- [Is the alcoholic really sober, does the applicant drink, can the pilot still fly? CDT test often fails in reliability!]. (2000) (0)
- [Current developments in roentgen diagnosis, computerized tomography and proton spin tomography in urology]. (1987) (0)
- Organ and Tissue Transplantation III (1999) (0)
- Causes for a low atherosclerotic response to dietary hypercholesterolemia in a strain of rabbits (1995) (0)
- [Carbohydrate-deficient transferrin (CDT) is modified by iron status: further reservations regarding the value of a new alcohol marker?]. (1999) (0)
- [Defective remnant clearance as a risk factor for coronary heart disease]. (1990) (0)
- Suppression of Apoprotein-E Receptor by LP-X (1986) (0)
- Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin‐induced extracorporeal LDL precipitation (HELP)* (1989) (0)
- Treatment of Severe Hypercholesterolemia in Patients with Coronary Heart Disease by Means of Lipoprotein Apheresis (1994) (0)
- Fett‐Transport im Plasma (1970) (0)
- The abnormal lipoprotein of cholestasis. (1971) (0)
- Crystalline hydrochloride of {(R) - (-) - [4- (1,1-dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl) -buytl] 2- N- aminomethyl} chroman (1995) (0)
This paper list is powered by the following services:
